VIRO

ATHANASIOS TASAOUSIS
Lernen

ATHANASIOS TASAOUSIS
Diese Lernkarten bieten einen grundlegenden Einblick in die Virologie, insbesondere in die Replikation von Viren. Sie behandeln Themen wie die Freisetzung von Viren aus Zellen, die Maturation von Viren und die Rolle von Proteinen bei der Virusvermehrung. Die Karteikarten sind ideal für Studierende und Forscher, die sich mit den grundlegenden Mechanismen der Virusreplikation vertraut machen möchten.
Karten
24
Lernende
1
Sprache
Deutsch
Kategorie
Recht
Stufe
Grundschule
Erstellt / Aktualisiert
01.06.2014 / 02.06.2014

Lernkarten

1) How is virus attachment mediated? What could the cellular receptor be?

Attachment of a virus to the new host cell involves specific interactions between its attachment protein (‘or antireceptor’) and the cellular receptor. The target receptor molecules may be proteins (mostly glycoproteins) or the carbonhdrate structures present on glycoproteins. Virus-receptor interactions involving carbonhydrate structures are considered to be less specific since sugar side chains of similar structure may be present in different glycosylated molecules in the membrane.

Some complex viruses (e.g. oixivuruses) use more than onee receptor and therefore have alternative ways of cell entry.

There are several classes of virus receptors (immunoglobulin-like superfamily molecules, membrane-associated receptors and transmembrane transporters and channels)

2) Describe virus-cellular receptor interactions in Picornaviridae (attachment). What is the receptor? How is the 'canyon' formed? How are the regions of the canyon involved in antibody binding and receptor binding?

Picornaviridae provide excellent examples for describing virus-receptor interactions since they have been extensively studied. ICAM-1, the receptor of the major human rhinovirus (HRV), is an adhesion molecule that normally functions by binding cells to adjacent substrates. It belongs to the immunoglobulin superfamily of molecules and its structure is characterized by constant (C) and variable (V) domains homologous to those of antibodies. The flanking monomers, VP1, VP2 and VP3, in the human rhinovirus (HRV) capsid form a deep cleft ,known as the ‘canyon’, in the surface of each triangular face of the icosahedral capsid. The floor of this canyon serves as the site of interaction between ICAM-1 and the virus particle. Unlike other areas of the virus surface, the amino acid residues forming the internal surfaces of the canyon are relatively invariant.  It was suggested that these regions are protected from antigenic pressure because the antibody molecules are too large to fit into the cleft.  This is important because radical changes here, although allowing the virus to escape an immune response, would disrupt receptor binding.  Subsequently, it has been found that the binding site of the receptor extends well over the edges of the canyon, and the binding sites of neutralizing antibodies extend over the rims of the canyon.  Nevertheless, the residues most significant for the binding site of the receptor and for neutralizing antibodies are separated from each other. 

3) Describe the example of poliovirus receptor? What are the similarities with picornavirus/

 Another member of the immunoglobulin superfamily, the poliovirus receptor (PVR or CD155), is an integral membrane protein that plays a role in the establishment of intracellular junctions between epithelial cells (also cas C and V domains). In polioviruses, there is a similar canyon that runs around each fivefold vertex of the capsid.  The highly variant regions of the capsid to which antibodies bind are located on the ‘peaks’ on either side of this trough, which is again too narrow to allow antibody binding to the residues at its base.  The invariant residues at the sides of the trough interact with the receptor.

4) Describe the example of influenza virus? How many types glycoprotein spikes are there? What are their structures and function?

Another well studied example, influenza virus. Two types of glycoprotein spikes are present on the surface of each particle,  a haemagglutinin spike and a neuraminidase protein. Each haemagglutin spike is made of three molecules and functions by mediating binding to the influenza virus receptor which is sialic acid (N-acetlyneuraminic acid), a sugar group present in a variety of glycosylated molecules. Little cell-type specificity results in influenza binding to a variety of cell type (e.g. causes haemagglutination of red blood cells) along cells in which productive infection occurs

Attachment of the virus to the cellular receptor is in most cases a reversible process- if penetration of the cells does not ensue, the virus can elute from the cell surface. The neuraminidase protein provides a mechanism for detachment, by cleaving sialic acid from sugar side-chains. The receptor molecule responsible for binding of influenza virus is widely distributed thus inappropriate binding can occur in a variety of cells or even cell debris. Elution from the cell surface following receptor binding can lead to alterations in the virus (e.g. loss or structural alteration of virus-atachement protein) that decrease or eliminate possibility of subsequent attachment to other cells

5) What is penetration? When does it occur? What are the mechanisms?

Penetration of the target cell normally occurs a very short time after attachment of the virus to its receptor in the cell membrane.  Unlike attachment, cell penetration is generally an energy-dependent process - that is, the cell must be metabolically active for this to occur.  Three main mechanisms are involved:

1.            Translocation of the entire virus particle across the cytoplasmic membrane of the cell.  This process is relatively rare among viruses and is poorly understood.  It must be mediated by proteins in the virus capsid and specific membrane receptors.

2.            Endocytosis of the virus into intracellular vacuoles.  This is probably the most common mechanism of virus entry into cells.  It does not require any specific virus proteins (other than those already utilized for receptor binding) but relies on the normal formation and internalization of coated pits at the cell membrane. 

3.            Fusion of the virus envelope (so this is only applicable to enveloped viruses) with the cell membrane.

6)  What is uncoating? Fusion can be considered a part of it? What happens during fusion/? Why is endocytosis dangerous?

Uncoating is a general term for the events that occur after penetration, in which the virus capsid is completely or partially removed and the virus genome is exposed, usually in the form of a nucleoprotein complex.  Unfortunately this is one of the stages of virus replication that has been least studied and is relatively poorly understood.  In one sense, the removal of a virus envelope that occurs during membrane fusion is part of the uncoating process. 

Fusion between virus envelopes and endosomal membranes is driven by virus fusion proteins (for example, influenza haemagglutinin or retrovirus transmembrane (TM) glycoproteins).  These are usually activated by the uncloaking of a previously hidden fusion domain as a result of conformational changes in the protein induced by the low pH inside the vesicle, although in some cases the fusion activity is triggered directly by receptor binding.  The initial events in uncoating may occur inside endosomes, being triggered by the change in pH as the endosome is acidified, or directly in the cytoplasm.  Proteins which form ion channels, or cations such as chloroquine and ammonium chloride, can be used to block the acidification of these vesicles and to determine whether events are occurring following the acidification of endosomes (e.g. pH-dependent membrane fusion) or directly at the cell surface or in the cytoplasm (e.g. pH-independent membrane fusion). 

Endocytosis is potentially dangerous for viruses, because if they remain in the vesicle too long they will be damaged by acidification or lysosomal enzymes.  Some viruses such as influenza can control this process. The influenza virus M2 protein is a membrane channel that allows entry of hydrogen ions into the nucleocapsid, facilitating uncoating.  The M2 protein is multifunctional and also has a role in influenza virus maturation (below).

7) Describe uncoating in picoraviruses. Which process is it tightly linked to?

In picornaviruses, penetration of the cytoplasm by exit of virus from endosomes is tightly linked to uncoating.  The acidic environment of the endosome causes a conformational change in the capsid which results in exposure of hydrophobic domains which are thought to interact with the endosomal membrane and form pores through which the genome passes into the cytoplasm.

8) How does the tructure of the nucleocapsid affect uncoating product? How does the structure and chem istry of the nucleocapid affect subsequent step in replication?

What is common about Herpesvirus, adenovirus, and polyomavirus capsids?

What r the chars of reovirus and poxivirus uncoating?


 

The product of uncoating depends on the structure of the virus nucleocapsid.  In some cases, it might be relatively simple (e.g. picornaviruses have a small basic protein of approximately 23 amino acids [VPg] covalently attached to the 5' end of the vRNA genome), or highly complex (e.g. retrovirus cores are highly ordered nucleoprotein complexes that contain, in addition to the diploid RNA genome, the reverse transcriptase enzyme responsible for converting the virus RNA genome into the DNA provirus). 

The structure and chemistry of the nucleocapsid determines the subsequent steps in replication.    Herpesvirus, adenovirus, and polyomavirus capsids undergo structural changes following penetration, but overall remain largely intact.  These capsids contain sequences that are responsible for attachment to the cytoskeleton, and this interaction allows uncoating (at nuclear pores) the transport of the entire capsid to the nucleus.  In reoviruses and poxviruses, complete uncoating does not occur, and many of the reactions of genome replication are catalysed by virus-encoded enzymes inside cytoplasmic particles which still resemble the mature virions.

9) What do u know about replication and its groups? What do u know about the firt group?

The replication strategy of any virus depends on the nature of its genetic material.  In this respect, all viruses can be divided into seven groups.  Such a scheme was first proposed by David Baltimore in 1971.   For viruses with RNA genomes in particular, genome replication and the expression of genetic information are inextricably linked. The control of gene expression determines the overall course of a virus infection (acute, chronic, persistent, or latent).

 

Class I: Double-stranded DNA

This class can be subdivided into two further groups: (a) replication is exclusively nuclear - replication of these viruses is relatively dependent on cellular factors; (b) replication occurs in cytoplasm,  (in which case the viruses have evolved (or acquired) all the necessary factors for transcription and replication

10) What is common in polyomavirus, papillomavirus and adenvorus replication-expression? What are the differences? What do polyomaviruses and adenoviruses encode?

Polyomaviruses and Papillomaviruses

Polyomaviruses are heavily dependent on cellular machinery for both replication and gene expression.  Polyomaviruses encode trans-acting factors (T-antigens) which stimulate transcription (and genome replication).  Papillomaviruses in particular are dependent on the cell for replication, a process which is confined in terminally differentiated keratinocytes.

Adenoviruses

Adenoviruses are also heavily dependent on the cellular apparatus for transcription, but they possess various mechanisms that specifically regulate virus gene expression.  These include trans-acting transcriptional activators such as the E1A protein, and post-transcriptional regulation of expression, which is achieved by alternative splicing of mRNAs and the virus-encoded VA RNAs.  Adenovirus infection of cells is divided into two stages, early and late, the latter phase commencing at the time when genome replication occurs.

11) What is common about Herpesviruses and poxiviruses replication-expression?

Herpesviruses are less reliant on cellular enzymes than the previous groups.  They encode many enzymes involved in DNA metabolism (e.g. thymidine kinase) and a number of trans-acting factors that regulate the temporal expression of virus genes, controlling the phases of infection.  Transcription of the large, complex genome is sequentially regulated in a cascade fashion.  At least 50 virus-encoded proteins are produced after transcription of the genome by host-cell RNA polymerase II.  Three distinct classes of mRNAs are made:α: Immediate-early (IE) mRNAs encode trans-acting regulators of virus transcription.β: (Delayed) early mRNAs encode further nonstructural regulatory proteins and some minor structural proteins.γ: Late mRNAs encode the major structural proteins.Synthesis of the early gene product turns off the immediate-early products and initiates genome replication.  Some of the late structural proteins (γ1) are produced independently of genome replication; others (γ2) are only produced after replication.  A virus-encoded DNA-dependent DNA polymerase and a DNA-binding protein are involved in genome replication, together with a number of enzymes (e.g. thymidine kinase) that alter cellular biochemistry. 

 

12) Poxiviruses q.11 follow up

Genome replication and gene expression in poxviruses are almost independent of cellular mechanisms (except for the requirement for host-cell ribosomes).  Poxvirus genomes encode numerous enzymes involved in DNA metabolism, virus gene transcription, and posttranscriptional modification of mRNAs.  Many of these enzymes are packaged within the virus particle enabling transcription and replication of the genome to occur in the cytoplasm (rather than in the nucleus, like all the families described above) almost totally under the control of the virus.  Gene expression is carried out by virus enzymes associated with the core of the particle and is divided into two rather indistinct phases: Early genes: These comprise about 50% of the poxvirus genome and are expressed before genome replication inside a partially uncoated core particle (Chapter 2), resulting in the production of 5' capped, 3' polyadenylated but unspliced mRNAs.Late genes: These are expressed after genome replication in the cytoplasm, but their expression is also dependent on virus-encoded rather than on cellular transcription proteins (which are located in the nucleus).

13) Genome class II: single stranded DNA:

the autonomous and the helper virus-dependent parvoviruses

The Geminiviridae

Replication occurs in the nucleus, involving the formation of a double-stranded intermediate which serves as a template for the synthesis of single-stranded progeny DNA.

Both the autonomous and the helper virus-dependent parvoviruses are highly reliant on host cell assistance for gene expression and genome replication.  This is presumably because the very small size of their genomes does not permit them to encode the necessary biochemical apparatus.  There viruses show an extreme form of parasitism, utilizing the normal functions present in the nucleus of their host cells for both expression and replication.  The members of the replication-defective Dependovirus genus of the Parvoviridae are entirely dependent on adenovirus or herpesvirus superinfection for the provision of further helper functions essential for their replication beyond those present in normal cells.  The adenovirus genes required as helpers are the early, transcriptional regulatory genes such as E1A.

The Geminiviridae also fall into this class of genome structures.  The expression of their genomes is quite different from that of parvoviruses but nevertheless still relies heavily on host-cell functions.  There are open reading frames in both orientations in the virus DNA, which means that both (+) and (–)sense strands are transcribed during infection. 

14) CLASS II: Double stranded RNA ( reovirus)

These viruses have segmented genomes.  Each segment is transcribed separately to produce individual monocistronic mRNAs.

Early in infection, transcription of the dsRNA genome segments by virus-specific transcriptase activity occurs inside partially uncoated subvirus particles resulting in capped transcripts that are not polyadenylated and which leave the virus core to be translated in the cytoplasm.  The various genome segments are transcribed/translated at different frequencies, which is perhaps the main advantage of a segmented genome.  RNA is transcribed conservatively; that is, only (–)sense strands are used, resulting in synthesis of (+)sense mRNAs, which are capped inside the core. Secondary transcription occurs later in infection inside new particles produced in infected cells and results in uncapped, nonpolyadenylated transcripts.  The genome is replicated in a conservative fashion with excess (+)sense strands being produced, serving  as late mRNAs and as templates for (–)sense strand synthesis

15) Single stranded (+) sense RNA

These can be subdivided into two groups: (a) Viruses with polycistronic mRNA (b) Viruses with complex transcription, for which two rounds of translation (e.g. togavirus) or subgenomic RNAs (e.g. tobamovirus) are necessary to produce the genomic RNA.

1.  Production of a polyprotein encompassing the whole of the virus genetic information, which is subsequently cleaved by proteases to produce precursor and mature polypeptides.  These cleavages can be a subtle way of regulating the expression of genetic information.  Alternative cleavages result in the production of various proteins with distinct properties from a single precursor (e.g. in picornaviruses). 

2.  Production of subgenomic mRNAs, resulting from two or more rounds of translation of the genome.  This strategy is used to achieve temporal separation of  the ‘early’  (nonstructural protein production) and ‘late’ phase (sturctural protein production) of replication. The proteins produced in each of these phases may result from proteolytic processing of a polyprotein precursor, although this encompasses only part of the virus genome rather than the entire genome, as above.  Proteolytic processing offers further opportunities for regulation of the ratio of different polypeptides produced in each phase of replication (e.g. in togaviruses). 

16) Single-stranded (-) sense RNA

The genomes of these viruses may be either segmented or nonsegmented. 

The first step in the replication of segmented orthomyxovirus genomes is transcription of the (–)sense vRNA by the virion-associated RNA-dependent RNA polymerase to produce (predominantly) monocistronic mRNAs, which also serve as the template for subsequent genome replication.  As with all (–)sense RNA viruses, packaging of this virus-specific transcriptase/replicase within the virus nucleocapsid is essential because no host cell contains any enzyme capable of decoding and copying the RNA genome.

In the other families that have nonsegmented genomes, monocistronic mRNAs are also produced.  Here, however, these messages must be produced from a single, long (–)sense RNA molecule.  Exactly how this is achieved is not clear.  It is possible that a single, genome-length transcript is cleaved after transcription to form the separate mRNAs, but it is more likely that these are produced individually by a stop-and-start mechanism of transcription regulated by the conserved intergenic sequences present between each of the virus genes.  Splicing mechanisms cannot be used because these viruses replicate in the cytoplasm.

17) Single-stranded (+)sense RNA with DNA intermediate

The retroviruses are the ultimate case of reliance on the host-cell transcription machinery.  The RNA genome forms a template for reverse transcription to DNA - these are the only (+)sense RNA viruses whose genome does not serve as mRNA on entering the host cell.  Once integrated into the host-cell genome, the DNA provirus is under the control of the host cell and is transcribed exactly as are other cellular genes.  Some retroviruses, however, have evolved a number of transcriptional and post-transcriptional mechanisms that allow them to control the expression of their genetic information.

18) Double-stranded DNA with RNA intermediate

Expression of the genomes of these viruses is complex and relatively poorly understood.  The hepadnaviruses contain a number of overlapping reading frames clearly designed to squeeze as much coding information as possible into a compact genome.  The Hepatitis B virus X gene encodes a transcriptional trans-activator believed to be analogous to the human T-cell leukaemia virus (HTLV) tax protein.  At least two mRNAs are produced from independent promoters, each of which encodes several proteins and the larger of which is also the template for reverse transcription during the formation of the virus particle. 

19) What is virus assembly? Where does it take place? What are lipid rafts?

The assembly process involves the collection of all the components necessary for the formation of the mature virion at a particular site in the cell.  The site of assembly depends on the site of replication within the cell and on the mechanism by which the virus is eventually released from the cell and varies for different viruses.  For example, in picornaviruses, poxviruses, and reoviruses, assembly occurs in the cytoplasm; in adenoviruses, polyomaviruses, and parvoviruses, it occurs in the nucleus.

 

Lipid rafts are membrane microdomains enriched with glycosphingolipids (or glycolipids), cholesterol, and a specific set of associated proteins.  A high level of saturated hydrocarbon chains in sphingolipids allows cholesterol to be tightly interleaved in these rafts.  The lipids in these domains differ from other membrane lipids in having relatively limited lateral diffusion in the membrane.  Lipid rafts have been implicated in a variety of cellular functions, such as apical sorting of proteins and signal transduction, but they are also used by viruses as platforms for cell entry (e.g. HIV, rotavirus), and as sites for particle assembly, budding, and release from the cell membrane (e.g. influenza virus, HIV, rotavirus).

20) How is assembly initiated/controlled? How can newly synthesizewd structural component levels increase? Assembly can be simple ore complex. When does incapsidation occur?

In most cases, assembly is initiated through anchoring of virus proteins by cellular membranes. In spite of considerable study, the control of virus assembly is generally not well understood.  In general, it is thought that rising intracellular levels of virus proteins and genome molecules reach a critical concentration and that this triggers the process.  Many viruses achieve high levels of newly synthesized structural components by concentrating these into subcellular compartments, visible in light microscopes, which are known as inclusion bodies.  These are a common feature of the late stages of infection of cells by many different viruses.  The size and location of inclusion bodies in infected cells is often highly characteristic of particular viruses, for example, rabies virus infection results in large perinuclear ‘Negri bodies,’ first observed using an optical microscope by Adelchi Negri in 1903.  Alternatively, local concentrations of virus structural components can be boosted by lateral interactions between membrane-associated proteins.  This mechanism is particularly important in enveloped viruses released from the cell by budding

Assembly may be a relatively simple process which is driven only by interactions between the subunits of the capsid and controlled by the rules of symmetry.  In other cases, assembly is a highly complex, multistep process involving not only virus structural proteins but also virus-encoded and cellular scaffolding proteins that act as templates to guide the assembly of virions.  The encapsidation of the virus genome may occur either early in the assembly of the particle (e.g. many viruses with helical symmetry are nucleated on the genome) or at a late stage, when the genome is stuffed into an almost completed protein shell.

21) What is maturation? What changes does it involve? Where do the enzymes involved come from?

Maturation is the stage of the replication cycle at which the virus becomes infectious.  This process usually involves structural changes in the virus particle that may result from specific cleavages of capsid proteins to form the mature products or conformational changes which occur in proteins during assembly.  Such events frequently lead structural changes in the capsid that may be detectable by measures such as differences in the antigenicity of incomplete and mature virus particles, which in some cases (e.g. picornaviruses) alters radically.  Similar effects can be mediated by internal structural alterations  such the condensation of nucleoproteins with the virus. Virus-encoded proteases are frequently involved in maturation, although cellular enzymes or a mixture of virus and cellular enzymes are used in some cases. In contrast with virus enzymes, cellular proteolytic enzymes may present lack of substrate specificity that could result in degradation of capsid proteins. Virus-encoded proteases are loaded into virus particles during assembly and are only activated when brought into close contact with their target sequence by the conformation of the capsid (e.g. by being placed in a local hydrophobic environment or by changes of pH or metal ion concentration inside the capsid). 

22) Maturation in retroviruses and influenza

The retrovirus core particle is composed of proteins from the gag gene, and the protease is packaged into the core before its release from the cell on budding.  During the budding process, the protease eventually cleaves the gag protein precursors into the mature products - the capsid, nucleocapsid, and matrix proteins of the mature virus particle. Native influenza virus haemagglutinin undergoes post-translational modification and at this stage exhibits receptor-binding activity.  However, the protein must be cleaved into two fragments (HA1 and HA2) to be able to produce membrane fusion during infection. Cellular trypsin-like enzymes are responsible for this process, which occurs in secretory vesicles  prior to release at the cell surface. Cleavage of haemagluttin is dependent on the influenza protein (M2) that lowers the pH of the endosomal comparment. Consequently,drugs such as amantadine and rimantadine act on M2 and inhibit replication. Similarly, retrovirus envelope glycoproteins require cleavage into the surface (SU) and transmembrane (TM) proteins for activity.  This process is also carried out by cellular enzymes but is in general poorly understood, but is a target for inhibitors which may act as antivirals.

23) How do different types of viruses are released? lytic (most non-enveloped), enveloped... What is budding?

Plant viruses face particular difficulties caused by the structure of plant cell walls when it comes to leaving cells and infecting others.  In response, they have evolved particular strategies to overcome this problem.  All other viruses escape the cell by one of two mechanisms.  For lytic viruses (such as most non-enveloped viruses), release is a simple process - the infected cell breaks open and releases the virus.  Enveloped viruses acquire their lipid membrane as the virus buds out of the cell through the cell membrane or into an intracellular vesicle prior to subsequent release.  Virion envelope proteins are picked up during this process as the virus particle is extruded.  This process is known as budding and in some cases may prove hazardous to the cell (e.g. paramyxoviruses) or not (retrociruses) the physical interaction of the capsid proteins on the inner surface of the cell membrane forces the particle out through the membrane. Assembly, maturation and release are usually simultaneous processes for virus particles formed by budding.  The type of membrane from which the virus buds depends on the virus concerned.  In most cases, budding involves cytoplasmic membranes (retroviruses, paramyxoviruses, coronaviruses) but in some cases can involve the nuclear membrane (herpesviruses).

24) alternative way of release

In a few cases, notably in human retroviruses such as HIV and HTLV, viruses prefer direct cell to cell spread rather than release into the external environment and reuptake by another cell.  This process requires intimate contact between cells and can occur at tight junctions between cells or in neurological synapses.  These structure have been subverted by human retroviruses which engineer a novel structure in infected cells known as a virological synapse to promote more efficient spread within the host organism.

The release of mature virus particles from susceptible host cells by budding presents a problem in that these particles are designed to enter, rather than leave, cells.  How do these particles manage to leave the cell surface?  The details are not known but there are clues as to how the process is achieved.  Certain virus envelope proteins are involved in the release phase of replication as well as in the initiating steps.  A good example of this is the neuraminidase protein of influenza virus.  In addition to being able to reverse the attachment of virus particles to cells via haemagglutinin, neuraminidase is also believed to be important in preventing the aggregation of influenza virus particles and may well have a role in virus release.  This process is targeted by newer drugs such as oseltamivir (trade name "Tamiflu") and zanamivir ("Relenza").  In recent years, a group of proteins known as viroporins has been discovered in a range of different viruses.  These are proteins that modify the permeability of cellular membranes and promote the release of viral particles from infected cells.  These proteins are usually not essential for the replication of viruses, but their presence often enhances virus growth.

Lernen